0 0 0 0 0 0 PDF下载 引用本文 PERMISSIONS Request permissions for this article from CCC. © REQUEST PERMISSIONS 评价本文 确定 放弃 *以上评分为匿名评价 试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。 已是订阅账户? 登录
研究样本包括200例心脏病专家和201例PCP(平均年龄50岁,主要为男性[76%]和白人[63%])。据报道,与PCP相比,更多的心脏病专家中度/极度熟悉2018年美国ACC/AHA血液胆固醇管理指南(分别为75%和58%)。尽管超过一半的心脏病专家(51%)和PCP(64%)发现指...
Randomized,Double-blind Placebo-controlled,Phase3,Study To Evaluate Lerodalcibep Long-term Efficacy And SafetyIn Patients With Or At Very-high Or High Risk, For Lipid-lowering Therapy SHASTA-2最终结果:在严重高甘油三酯血症(SH...
Inclisiran是一种新近研发的siRNA,在首次及第90天初始治疗后,每年皮下给药两次。本研究旨在评估inclisiran在真实世界人群中降低LDL-C的效果,研究纳入2022年2月至2023年5月开始使用inclisiran的美国门诊患者,所有患者接受了首次和90天初始剂量的inclisiran,并在基线和开始后12个月内进行了LDL-C测量。通过同时使用他...
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. | National Lipid Association OnlineNational Lipid Associaton
2013ACC/AHA 血脂指南推荐要点 心脏病学会(ACC )、 心脏学会(AHA )与 心肺血液 (NHLBI) 联合制定的 《2013 ACC/AHA 控制血液胆固醇降低成人动脉粥样硬化性心血管疾病 (ASCVD)风险指南》 (以下简称新指南 )于近日公布,指南全文 于 11 月 12 日的《循环》(Circulation) 和《 心脏病学学会 》(JACC )上。 【...
TITRATION OF LIPID LOWERING THERAPY AFTER LIPOPROTEIN (A) MEASUREMENT IN BLACK VS. WHITE INDIVIDUALS IN THE AHA LP(A) COHORT AHA-LP(A)队列中黑人与白人测量脂蛋白(A)后的降脂治疗滴定 PHYSICIAN PRESCRIBING PATTERNS, PERCEPTIONS AND KNOWLEDGE AROUND LIPID LOWERING GUIDELINES ...
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. | National Lipid Association Online 来自 mendeley.com 喜欢 0 阅读量: 39 作者: NL Associaton 被引量: 754 年份: 2013 ...
Impact of new lipid management guidelines on the treatment of extreme and very high‐risk patients: AACE/ACE and AHA/ACC guidelinesImpact of new lipid management guidelines on the treatment of extreme and very high‐risk patients: AACE/ACE and AHA/ACC guidelinesdoi:10.1111/1753-0407.12998Paul...
Back on track after its in-person hiatus, ACC22 stressed industry resilience, and featured practice-changing science and innovations